Found 49 matching trials
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects PHASE3 This study will assess the efficacy and safety of GI198745 0.5mg given once...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) PHASE4 This is an investigator-initiated study of safety, efficacy and tolerabilit...
Show More Location
Deaconess Clinic Gateway Health Center
Learn More & Join Trial
Metabolic Effects of Steroids in Obese Men NA Subjects will be randomized into 4 study groups: 1. Placebo; 2. Anastrazole...
Show More Location
University of California, San Diego
Learn More & Join Trial
For Cause Prostate Biopsy in REDUCE Population Trial N/A The REDUCE trial was conducted to determine whether dutasteride reduces the...
Show More Learn More & Join Trial
Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter PHASE4 The purpose of this study is to evaluate the efficacy and safety of dutaste...
Show More Location
GSK Clinical Trials Call Center
Learn More & Join Trial
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia PHASE3 This is a multicentre, randomised, double-blind, parallel group study in As...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer PHASE3 RATIONALE: Diagnostic procedures, such as ultrasound-guided biopsy, may hel...
Show More Location
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Learn More & Join Trial
Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) PHASE2 This study will determine if the drug dutasteride can improve weakness, mob...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia PHASE3 The aim of this Phase III study is to compare the efficacy, safety and tole...
Show More Location
Multiple Locations
Learn More & Join Trial
Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia PHASE3 Treatment of male pattern hair loss (MPHL) or androgenetic alopecia (AGA) w...
Show More Location
GSK Investigational Site
Learn More & Join Trial